- Datum23.04.2024
- Uhrzeit15:00 - 16:00 Uhr
- VeranstalterXTB
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenPassende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (NYSE)
Wikifolio
Passender Service zu Glaukos Corp.
Webinar zu Glaukos Corp.
Kursinformationen (NYSE)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)45,380-102,330
- Jahrestief / Hoch ($)74,745-102,330
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Glaukos Corp.
Termine von Glaukos Corp.
- Mai1Glaukos Corp.Q1 2024 Earnings Release
- Jul31Glaukos Corp.Q2 2024 Earnings Release
- Okt30Glaukos Corp.Q3 2024 Earnings Release
Beschreibung
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.